Observation (n = 155) | Gemcitabine (n = 154) | Erlotinib (n = 155) | ||||
---|---|---|---|---|---|---|
Parameter | Cost | QALY | Cost | QALY | Cost | QALY |
Maintenance | €702 | 0.202 | €8,487 | 0.256 | €10,551 | 0.241 |
Second-line | €7,449 | 0.114 | €6,412 | 0.103 | €6,637 | 0.103 |
Palliative care | €14,582 | 0.229 | €13,497 | 0.260 | €14,741 | 0.251 |
Total | €22,734 | 0.545 | €28,397 | 0.619 | €31,928 | 0.595 |
Difference from observation | – | – | €5,663 | 0.074 | €9,195 | 0.050 |
ICER | – | – | 76,625 [44,212 – 188,887] | 184,733 [94,559 – 1,186,736] |